EUPRAXIA PHARMACEUTICALS INC. Foreign Currency Transaction Gain (Loss), Unrealized
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$1.57 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-03-13
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|
| 2025-12-31 | -$1.57M 40-F · filed 2026-03-13 |
| 2024-12-31 | -$156.09K 40-F · filed 2026-03-13 |
| 2023-12-31 | $64.61K 40-F · filed 2025-03-20 |
| 2022-12-31 | $223.71K 40-F · filed 2024-04-01 |